Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies.

about

Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies.

Item

http://www.wikidata.org/entity/Q53837961

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@en

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@nl

type

Item

label

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@en

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@nl

prefLabel

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@en

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@nl

P1476

Progressive left ventricular d ...... ing cardiopulmonary therapies.

@en

P2093

Dennis M Super

http://www.w3.org/2001/XMLSchema#string

Irwin B Jacobs

http://www.w3.org/2001/XMLSchema#string

Mary Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.

HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

Dystrophin and mutations: one gene, several proteins, multiple phenotypes.

Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.

Left ventricular dysfunction in duchenne muscular dystrophy and genotype.

P304

e000783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OPENHRT-2018-000783

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David J Birnkrant

Robert C Bahler

P577

2018-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29531771

http://www.w3.org/2001/XMLSchema#string

P932

5845428

http://www.w3.org/2001/XMLSchema#string